Abstract Candidiasis is a term describing infections by yeasts from the genus Candida, and the type of infection encompassed by candidiasis ranges from superficial to systemic. Treatment of such infections often requires antifungals such as the azoles, but increased use of these drugs has led to selection of yeasts with increased resistance to these drugs. In this study, we used allicin, an allyl sulfur derivative of garlic, to demonstrate both its intrinsic antifungal activity and its synergy with the azoles, in the treatment of these yeasts in vitro. In this study, the MIC 50 and MIC 90 of allicin alone against six Candida spp. ranged from 0.05 to 25 lg/ml. However, when allicin was used in combination with fluconazole or ketoconazole, the MICs were decreased in some isolates. Our results demonstrated the existing synergistic effect between allicin and azoles in some of the Candida spp. such as C. albicans, C. glabrata and C. tropicalis, but synergy was not demonstrated in the majority of Candida spp. tested. Nonetheless, In vivo testing needs to be performed to support these findings.
Introduction
Nowadays, fungal infections such as candidiasis are becoming more prevalent in normal and immunocompromised hosts [1] . Candida spp. are the fourth most common agent of hospital-acquired bloodstream infections [2, 3] . Specifically, Candida albicans is the most frequently isolated yeast from clinical specimens, but non-C. albicans species are more commonly isolated from blood, urine, skin and upper respiratory tract [4] . In general, for treatment of candidiasis, azole drugs such as fluconazole and ketoconazole [5] are used, but with increasing usage of anticandidal agents, the number and variety of azole-resistant fungal strains have increased. Moreover, these antifungal drugs often have side effects, and the search for newer treatment regimes for safer and more effective treatment is warranted.
Essential oils are an example of natural (biological) compounds which when used in synergy with antimicrobial agents may increase the efficacies of these therapeutic agents [6] . Allicin, one of the volatile sulfur oil compounds from freshly crushed garlic (Allium sativum), has a variety of antimicrobial activities [7] . Allicin has been shown to reduce the concentrations of b-lactam antibiotics required for inhibiting the growth of Staphylococcus spp. and Pseudomonas aeruginosa [8] and also has antifungal activity against fungi [9] . Allitridium (diallyl trisulphide) as a popular breakdown product from allicin has been shown to have both in vitro and in vivo antifungal activity [10] . Another allicin derivative with antifungal activity against Aspergillus niger and Candida albicans is ajoene [11] [12] [13] .
Azoles disrupt ergosterol biosynthesis in fungi resulting in the formation of cell membrane with altered structure and function [5] . It was suggested that the mechanism of action of garlic on Candida albicans is through the destruction in cell membrane integrity [14] and inhibition of hyphae formation [15] . It has been demonstrated that the antimicrobial activity of garlic is related to both the allyl and sulfur groups in thiosulfinates such as allicin [16, 17] . Furthermore, the main mechanism of antibacterial activity of allicin is the total inhibition of RNA synthesis [18] , but for fungus especially Candida spp., the mode of action of allicin is not well understood although some of the probable mechanisms may include oxidative stress in cell membrane and inhibition of certain thiol-containing molecules [19, 20] .
In the present study, in vitro anticandidal activity of allicin alone and in combination with fluconazole and ketoconazole against six Candida species was investigated. A synergistic effect was seen between allicin and the two azole drugs in some species of Candida.
Materials and Methods

Sources of Isolates
Six clinical isolates from different Candida spp. from microbiological laboratories of University of Malaya Medical Center (UMMC), Kajang Hospital, Selangor and Seremban Hospital Negeri Sembilan were obtained. All samples were isolated from patients with systemic candidiasis. For control strains, C. albicans ATCC 14053, C. tropicalis ATCC 750, C. parapsilosis ATCC 22019, C. glabrata ATCC 2001, C. rugosa ATCC 10571 and C. krusei ATCC 6258 were employed. Each sample was maintained as sterile 20% (v/v) glycerol stocks and subcultured on Sabouraud dextrose agar (Difco Laboratories, Detroit, Michigan) at 35-37°C for 24-48 h to ensure viability and purity prior to testing.
Inoculum Preparation
Stock inoculum suspensions of the Candida spp. were prepared by picking five colonies from 24-h cultures grown on Sabouraud dextrose agar at 35°C and suspending in 5 ml of sterile saline (0.85%) v/v NaCl. Cell density was adjusted with spectrophotometric method at 530 nm wavelength to achieve the turbidity equivalent 0.5 McFarland standard. The dilution of yeast stock suspension was adjusted from 1 9 10 6 to 5 9 10 6 cells/ml.
Antifungal Agents
Allicin was purchased from Alexis Biochemicals Co.
(purity C 98%, Batch No. ALX-350-329, San Diego, USA) and dissolved at 10 mg/ml in methanol/water/ formic acid (60:40:0.1), then stored at -20 to -80°C. Fluconazole and ketoconazole were purchased from Sigma Chemicals Co. (St. Louis, Mo., USA). Stock solutions were prepared as follows: fluconazole and ketoconazole by dissolution in dimethyl sulfoxide (DMSO) at 5 and 1.5 mg/ml. The stock solutions were stored frozen at -70°C until the day of the test. Allicin, fluconazole and ketoconazole drug dilutions ranged, respectively, from 0.05 to 25 lg/ml, 0.03 to 64 lg/ml and 0.03 to 16 lg/ml.
Broth Microdilution Method (NCCLS M27 A 2 document) for Determination of MIC
U-bottom 96-well microplates (Brand 781660, Wertheim, Germany) containing 100 ll of the twofold dilution of the antifungal agents alone or 50 ll of each drug while in combination with allicin in standard RPMI 1640 medium with 0.2% glucose [buffered to pH 7.0 with 0.165 M morpholinophosphonyl sulfate (MOPS)] were inoculated with 100 ll of inoculum containing between 5 9 10 2 and 2.5 9 10 3 yeast cells/ml [21] . The cells were incubated at 35°C, and the MICs were determined after 24 and 48 h. MIC 90 and MIC 50 were assigned as the lowest concentration of the drugs (alone or in combination) that inhibited growth by 90% or 50%, respectively, of the strains tested [22] . Drug interaction was regulated as synergistic, additive, indifferent or antagonistic on the basis of the fractional inhibitory concentration (FIC) index. 
Results
The MIC range of allicin against Candida spp. after 24-and 48-h incubation was subsequently 0.05-3.13 lg/ml and 0.39-25 lg/ml. From Table 1 , it can be seen about 30% of the samples treated with combination of allicin/fluconazole after 24-h incubation at 35°C had synergistic or partial synergistic properties, while only 12.5% of the combination of allicin/ketoconazole after 24-h incubation at 35°C had synergistic or partial synergistic properties. Most of the samples showed indifferent reaction when the drugs were used in combination (Fig. 1) . Approximately, 12.5% of samples with combination of allicin/fluconazole after 48-h incubation at 35°C had FIC index of 0.5-1 (partial synergism), and no additive or antagonistic effect was observed (Table 2) . Moreover, for combination of allicin/ ketoconazole after 48-h incubation at 35°C, 21% of the samples had FIC index of 0.5-1, while antagonistic effect was not observed (Fig. 2) .
Discussion
Invasive fungal infections such as candidiasis have increased in prevalence worldwide over the last two decades, and consequently, the use of antifungal drugs such as azoles has increased [24, 25] . Triazole antifungal drugs such as fluconazole, and also imidazoles like ketoconazole, have significant roles in the treatment of candidiasis and other invasive fungal infections [5, 26] , but sometimes with the use of these agents, clinically important toxic effects such as skin rash, nausea, elevated liver enzyme (for fluconazole) gynecomastia, adrenal insufficiency and hepatotoxicity (for ketoconazole) are seen [27, 28] . Overtime, under some clinical settings, the efficacy of azoles has decreased due to increased resistance to the antifungals [5, 29] . Previous reports had demonstrated the efficacy of allicin used as monotherapy against some of the fungi such as Aspergillus spp., Trichophytun spp. and Candida spp. [7, 9, 30, 31] , with little adverse reaction and no antigenicity [32] . Garlic and some bioactive derivatives could destroy fungal cell membrane integrity, which could lead to cellular collapse being observed [15] . Allicin is also shown to be a growth inhibitor which inhibited succinate dehydrogenase in fungus [14] . Some researchers demonstrated that Cu 2? displayed anticandidal activity by increasing reactive oxygen species in the cell, and allicin could extend this property of Cu 2? when used in combination with Cu 2? . The main targets of this oxidative destruction were DNA, RNA, protein, sugars and phospholipids such as cell membrane phospholipids [33, 34] . Moreover, it is indicated that oxidative damage in cell membrane such as phospholipids peroxidation could be one of the probable mechanisms for synergistic effect between allicin and amphotericin B [19] . On the other hand, strong synergistic effect has been demonstrated between ajoene and ketoconazole against Microsporum canis [35] , but there is currently no information at all about the anticandidal activity of allicin in combination with azoles. In the present study, allicin was synergistic with the azoles with respect to some of the Candida spp. (see Tables 1, 2 ). The best example of this is that of synergy against C. rugosa (clinical isolate), where the MIC 90 of this isolate with synergistic effect of fluconazole and allicin was markedly decreased (62-fold) compared to the MICs of allicin and the azole alone (Table 1) . Nonetheless, our data show a relatively strong activity against all Candida spp. tested when allicin was used alone. For example, MIC 90 of allicin alone for C. albicans ATCC 14053 after 24-h incubation at 35°C was 0.1 lg/ml, and after 48-h incubation at 35°C, it was 3.13 lg/ml (Tables 1, 2) . Investigation of these results demonstrated that there was a difference between reading the results at 24 and 48 h. It is recommended to read the results after 24 h and not after 48 h for most of Candida spp. because it is possible that after 24-h incubation, allegorical yeast cells will be unviable in the wells of microplates showing partial inhibition [21, 36] . In addition, a 24-h MIC endpoint is critical for monitoring drug susceptibility in order to aid the clinicians in prescribing appropriate therapy. It is also applicable for animal model of candidiasis [37, 38] . On the other hand, for some of Candida spp. such as C. glabrata which has slow growth, reading the results after 48 h is more appropriate [39] .
Shadkchan et al. reported that the efficacy of allicin for inhibition of Aspergillus fumigatus in which allicin caused a tenfold reduction in fungal burden in infected mice [30] . In another study, the combination of allicin (1 mg/kg) and amphotericin B (0.5 mg/kg) significantly decreased the fungal cell count in the tissue of infected mice with systemic candidiasis [19] . In several reports, it is demonstrated that the chemical stability of allicin is not sufficient to enable its sustained bioavailability in the body. Nonetheless, the antifungal activity of allicin in a living body is related to some of the derivatives of this thiosulfinate compound such as diallyl disulfide, diallyl trisulfide and ajoene [16, 40] . However, the potential of allicin in combination with azoles as an anticandidal drug in animal models of candidiasis has not been investigated. These results from the present study warrant further investigations, on the possible synergistic effects of allicin with other type of antifungal drugs. The observed synergism between azoles and allicin in vitro should also be investigated in in vivo animal model of candidiasis. Moreover, further experiments could be performed in order to elucidate the molecular mechanisms underlying this synergistic effect.
